ArticleRSC advances2019

Diastereoselective approach to rationally design tetrahydro-β-carboline-isatin conjugates as potential SERMs against breast cancer.

Bharvi Sharma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.